Cannabix Technologies (CSE:BLO,OTCPINK:BLOZF) reported on the development of its breathalyzer, FAIMS (high-field asymmetric waveform ion mobility spectrometry), which was created for detection of trace amounts of tetrahydrocannabinol from exhaled breath at the roadside and in the workplace.
As quoted in the press release:

The Company is pleased to report that it has developed a “Beta 2.0” (Cannabix Marijuana Breathalyzer) device with major advances in the design and size of the device, including: greater sensitivity, improved performance by the square waveform generator. The current design includes features to allow for the addition of a rechargeable battery and touch screen and the device is approximately 10 times smaller than the Beta 1.0 device announced in July. Preliminary lab tests of the FAIMS device coupled with quadrupole ion trap mass spectrometry have shown lower levels of detection for THC standards than were achieved in past testing.
Scientific Testing for the FAIMS Cannabix Marijuana Breathalyzer
Cannabix scientists are formulating a scientific protocol to conduct live THC breath testing using the Beta 2.0 Cannabix Marijuana Breathalyzer in the coming weeks. The scientific testing will likely be conducted in Vancouver BC, Canada, where medical marijuana users will be engaged to determine the accuracy of the Beta 2.0 Cannabix Marijuana Breathalyzer to detect both smoked and edible consumption of marijuana in human breath. The results of the scientific tests will be used to prepare submissions for approval of the Cannabix Marijuana Breathalyzer as a court-approved device by the Minister of Justice in Canada and the National Highway and Safety Authority in the United States.

Click here for the full press release.


US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

Issuance of U.S. Patent No. 10,851,077 covering methods for extracting and concentrating cannabinoids using ultrasound-enhanced solvent extraction bolsters World Class’ intellectual patent portfolio

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announced the United States Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 10,851,077 on December 1, 2020 in relation to the Company’s methods for extracting and concentrating cannabinoids and other target compounds from cannabis using ultrasound-enhanced solvent extraction

Keep reading... Show less

Ubican brings well-known brands and is a trusted vendor with an established sales and marketing program

Chemesis International Inc. (CSE:CSI) (OTCQB:CADMF) (FRA:CWAA) (the “Company” or “Chemesis”), announces Ubican Global (“Ubican”) as its primary supplier for its United States VICKI program. Ubican is a trusted supplier of a family of brands, each with multiple types of products. The products include tinctures, digestibles, edibles, pet, beautyskincare, topical, edible, fitness, and smokable products

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce that it has engaged VisionWorks Engineering of San Diego, CA to commence engineering work to complete and test a proof of concept prototype of its nasal mist device.

This is a major milestone towards the ultimate goal for development of effective delivery methods and commercialization. The Company holds several provisional patent applications including for a nasal mist device entitled “Device and Method for the Treatment of Traumatic Brain Injuries and Post-Traumatic Stress Disorder”. This device includes a nasal delivery system for administration of pharmaceutical agents such as a psilocybin-derived agent and/or N-acetylcysteine (“NAC“) at preselected dosages and times. The device design allows for the precise control and delivery of medicines through the nasal cavity for faster and more efficient uptake of psychedelics and other medicines that target the brain.

Keep reading... Show less

Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) (“Next Green Wave“, “NGW” or the “Company”) is pleased to confirm the appointment of Ben Kovacs to the Company’s Board of Directors.

Mr. Kovacs was the former Chief Revenue Officer at NorCal Cannabis, one of the largest vertically integrated indoor producers in California. Mr. Kovacs is also the Chairman of a group of companies in the cannabis hardware space; this includes the international Octave & Myster brands.

Keep reading... Show less

 Storz & Bickel Gmbh & Go. (“Storz & Bickel”), a subsidiary of world-leading diversified cannabis, hemp, and vaporizer device company Canopy Growth Corporation (TSX: WEED ) (NASDAQ: CGC), has announced the release of 100 Volcano Classic Signature Edition versions of its world-renowned Volcano Classic vaporizer in celebration of its 20th anniversary. The engraved 24-karat plated commemorative edition of the iconic Volcano Classic arrives just in time for the holidays, making it a perfect gift option for discerning vape connoisseurs and collectors who value best-in-class performance and upscale aesthetics.

In addition to this special release, Storz & Bickel has produced a documentary chronicling Markus Storz and Jürgen Bickel’s storied history, from the invention of the table top Volcano to becoming the first company to produce medically-certified vaporizers, and ultimately their journey building one of the most widely known and respected vaporizer brands in the world. The documentary will be released in collaboration with Rolling Stone magazine, previewed on RollingStone.com starting December 4 . The full-length documentary will also be streamed on Storz & Bickel’s website.

Keep reading... Show less